Insulin Dose Adjustment (IDA)

Optimizing an insulin prescription is one of the most vexing challenges facing a busy primary care physician.  Our latest enhancement to the ALRT remote monitoring system can help.

The Insulin Dose Adjustment (IDA) feature will enable prescribing physicians using ALRT to compare a patient’s current prescribed insulin dose with the dose recommended by the American Academy of Clinical Endocrinologists and the American Diabetes Association given the patient’s weight, A1c level, and blood glucose readings.  If the IDA algorithm sees a discrepancy it will suggest a dose adjustment to more closely conform to the AACE and ADA guidelines.

ALRT will be offering more insulin dosing options for HCP as reference. Besides reference doses from AACE and ADA, the following will be added:

  • International Diabetes Federation (IDF)
  • Royal Australian College of General Practitioners (RACGP) and Diabetes Australia
  • Canadian Diabetes Association (CDA)
  • National Institute for Health and Care Excellence (NICE)
  • NZ-MOH (NZ Ministry of Health)

Additional reference dosing options will be added as the ALRT Diabetes Management Platform is introduced to other jurisdictions.

The IDA feature is intended only for insulin-requiring Type 2 diabetes patients to provide the HCP with reference doses. IDA is not indicated for patients who utilize insulin pumps and it is limited to adults with Type 2 diabetes on fixed dose regimen of insulin.